Tuesday, April 6, 2010

XMRV

. XMRV Virus - Threat To Blood Supply Probed

An infectious virus linked to two diseases, prostate cancer and chronic fatigue syndrome, is drawing the attention of public-health officials, who are investigating the potential threat to the nation's blood supply. Efforts are under way to find effective tests for the virus and determine its prevalence, led by a working group funded by the National Institutes of Health and including federal agencies such as the FDA and the Centers for Disease Control and Prevention. Blood banks, academic institutions and at least one advocacy group are also involved. The working group was established after a paper was published in October in the journal Science, where researchers reported finding the virus in a majority of 101 patients with chronic fatigue syndrome. The study's co-authors at the Whittemore Peterson Institute for Neuro-Immune Disease, the National Cancer Institute and the Cleveland Clinic, also found the virus in nearly 4% of 218 healthy people used as c ontrols in the study.
Amy Dockser Marcus, The Wall Street Journal
Related Links:
*
Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome
Judy A. Mikovits et al, 10.1126/science.1179052, Science Express

 4.
XMRV Virus Testing Available From WPI For UK ME/CFS Patients

This is a temporary site created for the purpose of facilitating communication between the Whittemore Peterson Institute USA and the UK study participants. UK study: We are scheduling London first. Those draws should take place as early as next week. More than 225 people emailed almost half home bound. We are planning now how to most efficiently draw the homebound. No one will be excluded from the study. Everyone will get individual results and the testing takes approximately 3 weeks.
Information Release, Whittemore Peterson Institute
Related Links:
*
Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome
Judy A. Mikovits et al, 10.1126/science.1179052, Science Express

No comments: